Inflammatory burden as a prognostic biomarker for cancer
Hailun Xie(Guangxi Medical University), Hanping Shi(Beijing Shijitan Hospital), Guo‐Tian Ruan(Beijing Friendship Hospital), Shiqi Lin(Nanjing University of Information Science and Technology), Chunhua Song(Zhengzhou University), Mengmeng Song(China Pharmaceutical University), Heyang Zhang(Academy of Military Medical Sciences), Kangping Zhang(Capital Medical University), Qi Zhang(Jiamusi University), Xi Zhang(Shanghai Jiao Tong University), Xiangrui Li(Institute of Plant Protection), Xiaoyue Liu(Capital Medical University), Ming Yang(Jiangsu University), Yi‐Zhong Ge(China International Science and Technology Cooperation), Meng Tang(Capital Medical University)
Cited by 152
Related Papers
Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation
|Oncogenesis|2016|259
Wnt/β-catenin signaling enhances hypoxia-induced epithelial–mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling
|Carcinogenesis|2013|256
Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
|Proceedings of the National Academy of Sciences|1996|226
Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study
|Frontiers in Immunology|2023|189
The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer
|Journal of Cachexia Sarcopenia and Muscle|2022|170